Founded In 2014Edinburgh Molecular Imagingem Imagingis A Clinical Phase Biotechnology Company Focused On Enabling Image Guided Therapythe Company S Molecular Imaging Technologybased On Fluorescent Imaginghas The Potential To Detect Disease In Real Time During Interventional Procedures Including Surgeryproviding More Accurate Treatment While Sparing Healthy Tissue A The Focus Of Em Imaging Is The Discovery And Development Of Small Molecules And Peptides Thatwhen Conjugated With Fluorescent Dyestarget And Specifically Cancerous Cells And Other Diseased Tissuethis Illumination Will Provide The Clinician With A Clearer View And Decision Making Tool To Benefit The Patient
